Shingles is a painful condition caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It typically affects older adults and can cause intense pain, itching, and a rash. Fortunately, there are vaccines available to help prevent shingles and its complications. In this article, we will explore the two main shingles vaccines, Shingrix and Zostavax, and determine which is the better option.
Understanding Shingles and Its Risks
Before we dive into the vaccines, it’s important to understand what shingles is and why it’s so concerning. Shingles occur when the varicella-zoster virus, which remains dormant in your body after you’ve had chickenpox, becomes active again. This can happen due to a weakened immune system, which is more common as we age. The result is a painful, blistering rash that often appears on one side of the body, typically on the torso.
Shingles can lead to complications, including postherpetic neuralgia (PHN), a condition that causes severe pain even after the rash has healed. This can significantly affect a person’s quality of life. The risk of developing shingles and its complications increases with age, particularly for those 50 years and older.
The Two Main Shingles Vaccines
There are currently two vaccines available for preventing shingles: Zostavax and Shingrix. Both vaccines are designed to boost the immune system’s ability to fight the varicella-zoster virus and reduce the risk of developing shingles. However, they differ in several key areas, such as their effectiveness, administration, and side effects.
Shingrix Vaccine
Shingrix is the newer of the two shingles vaccines. It was approved by the U.S. Food and Drug Administration (FDA) in 2017 and is currently the preferred vaccine for shingles prevention. Shingrix is a recombinant vaccine, which means it contains pieces of the varicella-zoster virus, rather than a live virus. This helps to stimulate a stronger immune response without causing an actual infection.
Shingrix is administered in two doses, with the second dose given two to six months after the first. It is recommended for adults aged 50 years and older, regardless of whether they have had shingles before or received the Zostavax vaccine.
Zostavax Vaccine
Zostavax is an older vaccine, first approved by the FDA in 2006. Unlike Shingrix, Zostavax is a live vaccine, meaning it contains a weakened version of the varicella-zoster virus. Zostavax is given as a single dose and is also recommended for adults aged 60 years and older.
However, due to its lower effectiveness compared to Shingrix, Zostavax is now considered a secondary option. It is no longer the preferred vaccine for shingles prevention, especially for those under 70 years of age.
Comparing the Effectiveness of Shingrix and Zostavax
One of the most important factors when choosing a vaccine is its effectiveness. Let’s compare how well each vaccine works to prevent shingles.
Shingrix Effectiveness
Shingrix has proven to be highly effective in preventing shingles. Clinical studies have shown that it is about 90% effective at preventing shingles in adults aged 50 and older. This high level of protection remains strong for at least four years after receiving both doses. In addition to preventing shingles, Shingrix also significantly reduces the risk of developing postherpetic neuralgia (PHN), a common complication of shingles.
Zostavax Effectiveness
Zostavax, on the other hand, is less effective than Shingrix. It has an efficacy rate of around 51% in preventing shingles in adults aged 60 and older. While this may seem somewhat effective, it’s important to note that its protection decreases over time. Studies have shown that the vaccine’s effectiveness wanes significantly after just a few years, particularly in older adults. Zostavax is also less effective at preventing PHN, making it a less reliable choice in terms of long-term protection.
Side Effects of Shingrix vs. Zostavax
Like all vaccines, both Shingrix and Zostavax can cause side effects. It’s important to consider these potential side effects when choosing the best vaccine for shingles prevention.
Shingrix Side Effects
Shingrix is generally well-tolerated, but some people may experience side effects. The most common side effects include:
- Pain, redness, or swelling at the injection site
- Fatigue
- Muscle pain
- Headache
- Fever
- Chills
These side effects usually go away within a few days. Some people may also experience more intense reactions after the second dose of Shingrix, but this is typically a sign that the immune system is responding to the vaccine.
Zostavax Side Effects
Zostavax also has side effects, although they are generally less intense than those of Shingrix. Common side effects of Zostavax include:
- Pain, redness, or swelling at the injection site
- Headache
- Fever
Because Zostavax is a live vaccine, there is a small risk of developing a mild case of shingles or chickenpox, especially in people with weakened immune systems. However, this risk is very low and generally occurs in immunocompromised individuals.
Duration of Protection
One of the most important factors to consider when choosing a shingles vaccine is how long the protection lasts.
Shingrix Duration of Protection
Shingrix provides long-lasting protection against shingles. Studies have shown that its effectiveness remains high for at least four years after the second dose, and ongoing research suggests that it may provide even longer protection. While the exact duration is still being studied, the current data indicates that Shingrix offers significantly longer protection than Zostavax.
Zostavax Duration of Protection
Zostavax offers protection against shingles, but this protection begins to decline after a few years. According to studies, Zostavax’s effectiveness decreases by about 20% every year after the vaccine is administered. By about five years after receiving Zostavax, the vaccine’s protection drops to about 40%. This is why Zostavax is no longer the preferred vaccine for shingles prevention.
Cost and Availability
Both Shingrix and Zostavax are widely available at pharmacies, doctors’ offices, and clinics. The cost of these vaccines can vary depending on location and whether you have insurance coverage.
Shingrix Cost
Shingrix is generally more expensive than Zostavax. The cost of Shingrix is typically around $150 to $200 per dose, making the total cost for both doses between $300 and $400. However, most insurance plans cover the cost of Shingrix for adults aged 50 and older, and many people may be able to get the vaccine at little or no cost.
Zostavax Cost
Zostavax is less expensive, with a single dose typically costing around $200 to $250. However, as mentioned earlier, Zostavax is no longer the preferred vaccine due to its lower effectiveness and shorter duration of protection.
Who Should Get Shingrix or Zostavax?
The Centers for Disease Control and Prevention (CDC) recommends that adults aged 50 and older receive the Shingrix vaccine, even if they have already had shingles or received the Zostavax vaccine in the past. Shingrix is recommended for everyone in this age group, as it provides stronger protection and has a longer duration of effectiveness.
Zostavax may still be an option for those who are unable to receive Shingrix, but it is no longer the first choice due to its reduced efficacy and shorter protection duration.
Conclusion: Which Shingles Vaccine is Better?
Based on the comparison of Shingrix and Zostavax, it is clear that Shingrix is the better option for shingles prevention. It offers higher effectiveness, longer-lasting protection, and a lower risk of complications like postherpetic neuralgia. Although Shingrix may cause more intense side effects in some individuals, these side effects are typically short-lived and are a sign that the immune system is responding to the vaccine.
While Zostavax may still be appropriate for certain individuals, especially those who cannot receive Shingrix, it is no longer the preferred choice. Shingrix is the best option for most adults aged 50 and older and provides the highest level of protection against shingles and its complications.
If you are unsure which vaccine is best for you, consult your healthcare provider. They can help determine which vaccine is most appropriate based on your medical history and any underlying health conditions.
Related topics
